| Expression of truncated HER2 and its prognostic value in HER2-positive breast cancer patients AM Maria, M El-Shebiney, AM El-Saka, Y Zamzam Journal of the Egyptian National Cancer Institute 30 (2), 49-55, 2018 | 10 | 2018 |
| Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer M El-Shebiney, N El-Mashad, W El-Mashad, AA El-Ebiary, AE Kotkat Journal of the Egyptian National Cancer Institute 30 (1), 33-38, 2018 | 10 | 2018 |
| Treatment outcome of gestational trophoblastic neoplasia A Maria, M El-Shebiney, E Sadaka, M Ramadan J Am Sci 8 (11), 261-7, 2012 | 5 | 2012 |
| Poor survival outcome of docetaxel every three weeks plus prednisone for treatment of patients with hormone-refractory metastatic prostate cancer S Mansour, M El Shebiney, NM Abd El Bary, E Sadaka, A Maria Hematology/Oncology and Stem Cell Therapy 3 (3), 121-127, 2010 | 4 | 2010 |
| Definitive radiation therapy for early glottic carcinoma A Maria, M El-Shebiney, O Abd El-Fattah Life Science Journal 9 (2), 2012 | 1 | 2012 |
| Lymph node ratio as a prognostic factor in stage III colon cancer E Sadaka, A Maria, M El-Shebiney Journal of American Science 8 (9), 1137-41, 2012 | 1 | 2012 |
| Performance status and the number of the metastatic sites are powerful prognostic factors in patients with carcinomas of unknown primary site M El-Shebiney, A Maria J Am Science 7 (10), 442-447, 2011 | 1 | 2011 |
| THREE-WEEKLY DOCETAXEL WITH PREDNISOLONE FOR PATIENTS WITH HORMONE-REFRACTORY METASTATIC PROSTATE CANCER: PRELIMINARY RESULTS S Mansour, A Maria, E Sadaka, M El Shebiney, N Abd El Bary Kasr Al-Ainy Center of Clinical Oncology & Nuclear Medicine, 2017 | | 2017 |
| Management of gastrointestinal stromal tumors: Five years period, Tanta experience M El-Shebiney, A Maria, E Sadaka, A El-Namer Life Science Journal 10 (1), 2013 | | 2013 |
| Gemcitabine plus capecitabine versus gemcitabine plus oxaliplatin for patients with advanced pancreatic cancer M El-Shebiney, A Maria Life Science Journal 9 (2s), 2012 | | 2012 |
| Prognostic factors for supraclavicular relapse in N1 breast cancer patients. May that judge the need for supraclavicular irradiation? E Sadaka, A Maria, M El-Shebiney Journal of American Science 8 (10), 2012 | | 2012 |
| The role of post-mastectomy radiotherapy in node negative breast cancer with tumor size 5 cm or larger A Maria, M El-Shebiney Journal of American Science 8 (4), 2012 | | 2012 |
| Three Weekly Docetaxel plus Predinsolone for Patients with Hormone-Refractory Metastatic Prostate Cancer: Preliminary Result M Abd El Halim, S Mansour, MM El Shebiney, NM Abd El Barny, ... Journal of Men's Health 3 (7), 295-296, 2010 | | 2010 |
| THREE-WEEKLY DOCETAXEL WITH PREDNISOLONE FOR PATIENTS WITH HORMONE-REFRACTORY METASTATIC PROSTATE CANCER: PRELIMINARY RESULTS AEH Abu-Hamar, S Mansour, M El Shebiney, N Abd El Bary, E Sadaka, ... Research in Oncology 5 (3-4), 31-37, 2009 | | 2009 |
| The Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Resectable Non-Metastatic Breast Cancer M El-Shebiney, A Maria, MT Abdelghafar | | |
| Modified FOLFIRINOX Regimen as Front-Line Therapy for Metastatic Pancreatic Adenocarcinoma M El-Shebiney, A Maria | | |
